After in-licensing and developing multiple other compounds and taking the company public through a reverse merger, Shkreli was ousted from ... ...read more
Growth Capitalist (https://growthcapitalist.com/2016/09/retrophin-drug-licensed-by-shkreli-shows-positive-phase-2-results/)
After in-licensing and developing multiple other compounds and taking the company public through a reverse merger, Shkreli was ousted from ... ...read more